The role of infection and comorbidity: Factors that influence disparities in sepsis

被引:271
作者
Esper, Annette M. [1 ]
Moss, Marc
Lewis, Charmaine A.
Nisbet, Rachel
Mannino, David M.
Martin, Greg S.
机构
[1] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA
[2] Univ Kentucky, Dept Med, Div Pulm & Crit Care, Lexington, KY 40506 USA
关键词
sepsis; healthcare disparities; comorbidities; infection;
D O I
10.1097/01.CCM.0000239114.50519.0E
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. Large healthcare disparities exist in the incidence of sepsis based on both race and gender. We sought to determine factors that may influence the occurrence of these healthcare disparities, with respect to the source of infection, causal organisms, and chronic comorbid medical conditions. Design: Historical cohort study. Setting: U.S. acute care hospitals from 1979 to 2003. Patients: Hospitalized patients with a diagnosis of sepsis were identified from the National Hospital Discharge Survey per codes of the International Statistical Classification of Diseases, Ninth Revision (ICD-9CM). Chronic comorbid medical conditions and the source and type of infection were characterized by corresponding ICD-9CM diagnoses. Interventions., None. Measurements and Main Results. Sepsis incidence rates are mean cases per 100,000 after age adjustment to the 2000 U.S. Census. Males and nonwhite races were confirmed at increased risk for sepsis. Both proportional source distribution and incidence rates favored respiratory sources of sepsis in males (36% vs. 29%, p <.01) and genitourinary sources in females (35% vs. 27%, p <.01). Incidence rates for all common sources of sepsis were greater in nonwhite races, but proportional source distribution was approximately equal. After stratification by the source of infection, males (proportionate ratio 1.16, 95% confidence interval 1.04-1.29) and black persons (proportionate ratio 1.25, 95% confidence interval 1.18-1.32) remained more likely to have Gram-positive infections. Chronic comorbid conditions that alter immune function (chronic renal failure, diabetes mellitus, HIV, alcohol abuse) were more common in nonwhite sepsis patients, and cumulative comorbidities were associated with greater acute organ dysfunction. Compared with white sepsis patients, nonwhite sepsis patients had longer hospital length of stay (2.0 days, 95% confidence interval 1.9-2.1) and were less likely to be discharged to another medical facility (30% whites, 25% blacks, 18% other races). Case-fatality rates were not significantly different across racial and gender groups. Conclusions: Healthcare disparities exist in the incidence of sepsis within all major sources of infection, and males and blacks have greater frequency of Gram-positive infections independent of the infection source. The differential distribution of specific chronic comorbid medical conditions may contribute to these disparities. Large cohort and administrative studies are required to confirm discrete root causes of sepsis disparities.
引用
收藏
页码:2576 / 2582
页数:7
相关论文
共 49 条
  • [1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
    Abraham, E
    Reinhart, K
    Opal, S
    Demeyer, I
    Doig, C
    Rodriguez, AL
    Beale, R
    Svoboda, P
    Laterre, PF
    Simon, S
    Light, B
    Spapen, H
    Stone, J
    Seibert, A
    Peckelsen, C
    De Deyne, C
    Postier, R
    Pettilä, V
    Sprung, CL
    Artigas, A
    Percell, SR
    Shu, V
    Zwingelstein, C
    Tobias, J
    Poole, L
    Stolzenbach, JC
    Creasey, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 238 - 247
  • [2] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    Abraham, E
    Laterre, P
    Garg, R
    Levy, H
    Talwar, D
    Trzaskoma, BL
    Francois, B
    Guy, JS
    Bruckmann, M
    Rea-Neto, A
    Rossaint, R
    Perrotin, D
    Sablotzki, A
    Arkins, N
    Utterback, BG
    Macias, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341
  • [3] *AG HEALTHC RES QU, 2004, NAT HEALTHC DISP REP
  • [4] Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
    Alberti, C
    Brun-Buisson, C
    Burchardi, H
    Martin, C
    Goodman, S
    Artigas, A
    Sicignano, A
    Palazzo, M
    Moreno, R
    Boulmé, R
    Lepage, E
    Le Gall, JR
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (02) : 108 - 121
  • [5] Systemic inflammatory response and progression to severe sepsis in critically ill infected patients
    Alberti, C
    Brun-Buisson, C
    Chevret, S
    Antonelli, M
    Goodman, SV
    Martin, C
    Moreno, R
    Ochagavia, AR
    Palazzo, M
    Werdan, K
    Le Gall, JR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (05) : 461 - 468
  • [6] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [7] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [8] [Anonymous], 2003, Unequal treatment: Confronting racial and ethnic disparities in health care
  • [9] Gender differences in cytokine secretion by human peripheral blood mononuclear cells:: Role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model
    Asai, K
    Hiki, N
    Mimura, Y
    Ogawa, T
    Unou, K
    Kaminishi, M
    [J]. SHOCK, 2001, 16 (05): : 340 - 343
  • [10] Determinants of postintensive care unit mortality: A prospective multicenter study
    Azoulay, E
    Adrie, C
    De Lassence, A
    Pochard, F
    Moreau, D
    Thiery, G
    Cheval, C
    Moine, P
    Garrouste-Orgeas, M
    Alberti, C
    Cohen, Y
    Timsit, JF
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (02) : 428 - 432